-
1
-
-
84867606428
-
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma
-
D. Sturm, H. Witt, V. Hovestadt, D.A. Khuong-Quang, D.T. Jones, C. Konermann, and et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma Cancer Cell 22 2012 425 437
-
(2012)
Cancer Cell
, vol.22
, pp. 425-437
-
-
Sturm, D.1
Witt, H.2
Hovestadt, V.3
Khuong-Quang, D.A.4
Jones, D.T.5
Konermann, C.6
-
2
-
-
84885074034
-
The somatic genomic landscape of glioblastoma
-
C.W. Brennan, R.G. Verhaak, A. McKenna, B. Campos, H. Noushmehr, S.R. Salama, and et al. The somatic genomic landscape of glioblastoma Cell 155 2013 462 477
-
(2013)
Cell
, vol.155
, pp. 462-477
-
-
Brennan, C.W.1
Verhaak, R.G.2
McKenna, A.3
Campos, B.4
Noushmehr, H.5
Salama, S.R.6
-
3
-
-
20044372154
-
MGMT gene silencing and benefit from temozolomide in glioblastoma
-
M.E. Hegi, A.C. Diserens, T. Gorlia, M.F. Hamou, N. de Tribolet, M. Weller, J.M. Kros, J.A. Hainfellner, W. Mason, L. Mariani, J.E. Bromberg, P. Hau, R.O. Mirimanoff, J.G. Cairncross, R.C. Janzer, and R. Stupp MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003
-
(2005)
N Engl J Med
, vol.352
, pp. 997-1003
-
-
Hegi, M.E.1
Diserens, A.C.2
Gorlia, T.3
Hamou, M.F.4
De Tribolet, N.5
Weller, M.6
Kros, J.M.7
Hainfellner, J.A.8
Mason, W.9
Mariani, L.10
Bromberg, J.E.11
Hau, P.12
Mirimanoff, R.O.13
Cairncross, J.G.14
Janzer, R.C.15
Stupp, R.16
-
4
-
-
84865558322
-
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: The Nordic randomised, phase 3 trial
-
A. Malmstrom, B.H. Gronberg, C. Marosi, R. Stupp, D. Frappaz, H. Schultz, U. Abacioglu, B. Tavelin, B. Lhermitte, M.E. Hegi, J. Rosell, R. Henriksson Nordic Clinical Brain Tumor Study Group (NCBTSG) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial Lancet Oncol 13 2012 916 926
-
(2012)
Lancet Oncol
, vol.13
, pp. 916-926
-
-
Malmstrom, A.1
Gronberg, B.H.2
Marosi, C.3
Stupp, R.4
Frappaz, D.5
Schultz, H.6
Abacioglu, U.7
Tavelin, B.8
Lhermitte, B.9
Hegi, M.E.10
Rosell, J.11
Henriksson, R.12
-
5
-
-
84863091424
-
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: The NOA-08 randomised, phase 3 trial
-
W. Wick, M. Platten, C. Meisner, J. Felsberg, G. Tabatabai, M. Simon, G. Nikkhah, K. Papsdorf, J.P. Steinbach, M. Sabel, S.E. Combs, J. Vesper, C. Braun, J. Meixensberger, R. Ketter, R. Mayer-Steinacker, G. Reifenberger, M. Weller NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial Lancet Oncol 13 2012 707 715
-
(2012)
Lancet Oncol
, vol.13
, pp. 707-715
-
-
Wick, W.1
Platten, M.2
Meisner, C.3
Felsberg, J.4
Tabatabai, G.5
Simon, M.6
Nikkhah, G.7
Papsdorf, K.8
Steinbach, J.P.9
Sabel, M.10
Combs, S.E.11
Vesper, J.12
Braun, C.13
Meixensberger, J.14
Ketter, R.15
Mayer-Steinacker, R.16
Reifenberger, G.17
Weller, M.18
-
6
-
-
84868019401
-
Personalized care in neuro-oncology coming of age: Why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice
-
M. Weller, R. Stupp, M.E. Hegi, M. van den Bent, J.C. Tonn, M. Sanson, W. Wick, and G. Reifenberger Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice Neuro Oncol 14 Suppl 4 2012 iv100 iv108
-
(2012)
Neuro Oncol
, vol.14
, pp. iv100-iv108
-
-
Weller, M.1
Stupp, R.2
Hegi, M.E.3
Van Den Bent, M.4
Tonn, J.C.5
Sanson, M.6
Wick, W.7
Reifenberger, G.8
-
7
-
-
73349121355
-
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: A report from EORTC Brain Tumor Group Study 26951
-
M.J. van den Bent, H.J. Dubbink, M. Sanson, C.R. van der Lee-Haarloo, M. Hegi, J.W. Jeuken, A. Ibdaih, A.A. Brandes, M.J. Taphoorn, M. Frenay, D. Lacombe, T. Gorlia, W.N. Dinjens, and J.M. Kros MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951 J Clin Oncol 9 2009 5881 5886
-
(2009)
J Clin Oncol
, vol.9
, pp. 5881-5886
-
-
Van Den Bent, M.J.1
Dubbink, H.J.2
Sanson, M.3
Van Der Lee-Haarloo, C.R.4
Hegi, M.5
Jeuken, J.W.6
Ibdaih, A.7
Brandes, A.A.8
Taphoorn, M.J.9
Frenay, M.10
Lacombe, D.11
Gorlia, T.12
Dinjens, W.N.13
Kros, J.M.14
-
8
-
-
84888229904
-
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
-
W. Wick, C. Meisner, B. Hentschel, M. Platten, A. Schilling, B. Wiestler, M.C. Sabel, S. Koeppen, R. Ketter, M. Weiler, G. Tabatabai, A. von Deimling, D. Gramatzki, M. Westphal, G. Schackert, M. Loeffler, M. Simon, G. Reifenberger, and M. Weller Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation Neurology 81 2013 1515 1522
-
(2013)
Neurology
, vol.81
, pp. 1515-1522
-
-
Wick, W.1
Meisner, C.2
Hentschel, B.3
Platten, M.4
Schilling, A.5
Wiestler, B.6
Sabel, M.C.7
Koeppen, S.8
Ketter, R.9
Weiler, M.10
Tabatabai, G.11
Von Deimling, A.12
Gramatzki, D.13
Westphal, M.14
Schackert, G.15
Loeffler, M.16
Simon, M.17
Reifenberger, G.18
Weller, M.19
-
9
-
-
84886445555
-
MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic oligodendrogliomas and oligoastrocytomas. A report from EORTC study 26951
-
M.J. van den Bent, L. Erdem-Eraslan, A. Idbaih, J.J. de Rooi, P.H. Eilers, W. Spliet, W.F. den Dunnen, C. Tijssen, P. Wesseling, P.A. Sillevis Smitt, J.M. Kros, T. Gorlia, and P.J. French MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic oligodendrogliomas and oligoastrocytomas. A report from EORTC study 26951 Clin Cancer Res 19 2013 5513 5522
-
(2013)
Clin Cancer Res
, vol.19
, pp. 5513-5522
-
-
Van Den Bent, M.J.1
Erdem-Eraslan, L.2
Idbaih, A.3
De Rooi, J.J.4
Eilers, P.H.5
Spliet, W.6
Den Dunnen, W.F.7
Tijssen, C.8
Wesseling, P.9
Sillevis Smitt, P.A.10
Kros, J.M.11
Gorlia, T.12
French, P.J.13
-
10
-
-
84858796263
-
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
-
S. Turcan, D. Rohle, A. Goenka, L.A. Walsh, F. Fang, E. Yilmaz, C. Campos, A.W. Fabius, C. Lu, P.S. Ward, C.B. Thompson, A. Kaufman, O. Guryanova, R. Levine, A. Heguy, A. Viale, L.G. Morris, J.T. Huse, I.K. Mellinghoff, and T.A. Chan IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype Nature 483 2012 479 483
-
(2012)
Nature
, vol.483
, pp. 479-483
-
-
Turcan, S.1
Rohle, D.2
Goenka, A.3
Walsh, L.A.4
Fang, F.5
Yilmaz, E.6
Campos, C.7
Fabius, A.W.8
Lu, C.9
Ward, P.S.10
Thompson, C.B.11
Kaufman, A.12
Guryanova, O.13
Levine, R.14
Heguy, A.15
Viale, A.16
Morris, L.G.17
Huse, J.T.18
Mellinghoff, I.K.19
Chan, T.A.20
more..
-
11
-
-
84866542816
-
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
-
P. Bady, D. Sciuscio, A.C. Diserens, J. Bloch, M.J. van den Bent, C. Marosi, P.Y. Dietrich, M. Weller, L. Mariani, F.L. Heppner, D.R. McDonald, D. Lacombe, R. Stupp, M. Delorenzi, and M.E. Hegi MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status Acta Neuropathol 124 2012 547 560
-
(2012)
Acta Neuropathol
, vol.124
, pp. 547-560
-
-
Bady, P.1
Sciuscio, D.2
Diserens, A.C.3
Bloch, J.4
Van Den Bent, M.J.5
Marosi, C.6
Dietrich, P.Y.7
Weller, M.8
Mariani, L.9
Heppner, F.L.10
McDonald, D.R.11
Lacombe, D.12
Stupp, R.13
Delorenzi, M.14
Hegi, M.E.15
-
12
-
-
78650019179
-
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
-
M.E. Figueroa, O. Abdel-Wahab, C. Lu, P.S. Ward, J. Patel, A. Shih, Y. Li, N. Bhagwat, A. Vasanthakumar, H.F. Fernandez, M.S. Tallman, Z. Sun, K. Wolniak, J.K. Peeters, W. Liu, S.E. Choe, V.R. Fantin, E. Paietta, B. Löwenberg, J.D. Licht, L.A. Godley, R. Delwel, P.J.M. Valk, C.B. Thompson, R.L. Levine, and A. Melnick Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 18 2010 553 567
-
(2010)
Cancer Cell
, vol.18
, pp. 553-567
-
-
Figueroa, M.E.1
Abdel-Wahab, O.2
Lu, C.3
Ward, P.S.4
Patel, J.5
Shih, A.6
Li, Y.7
Bhagwat, N.8
Vasanthakumar, A.9
Fernandez, H.F.10
Tallman, M.S.11
Sun, Z.12
Wolniak, K.13
Peeters, J.K.14
Liu, W.15
Choe, S.E.16
Fantin, V.R.17
Paietta, E.18
Löwenberg, B.19
Licht, J.D.20
Godley, L.A.21
Delwel, R.22
Valk, P.J.M.23
Thompson, C.B.24
Levine, R.L.25
Melnick, A.26
more..
-
13
-
-
78651463452
-
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of [alpha]-ketoglutarate-dependent dioxygenases
-
W. Xu, H. Yang, Y. Liu, Y. Yang, P. Wang, S.H. Kim, S. Ito, C. Yang, P. Wang, M.T. Xiao, L.X. Liu, W.Q. Jiang, J. Liu, J.Y. Zhang, B. Wang, S. Frye, Y. Zhang, Y.H. Xu, Q.Y. Lei, K.L. Guan, S.M. Zhao, and Y. Xiong Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of [alpha]-ketoglutarate-dependent dioxygenases Cancer Cell 19 2011 17 30
-
(2011)
Cancer Cell
, vol.19
, pp. 17-30
-
-
Xu, W.1
Yang, H.2
Liu, Y.3
Yang, Y.4
Wang, P.5
Kim, S.H.6
Ito, S.7
Yang, C.8
Wang, P.9
Xiao, M.T.10
Liu, L.X.11
Jiang, W.Q.12
Liu, J.13
Zhang, J.Y.14
Wang, B.15
Frye, S.16
Zhang, Y.17
Xu, Y.H.18
Lei, Q.Y.19
Guan, K.L.20
Zhao, S.M.21
Xiong, Y.22
more..
-
14
-
-
84929999099
-
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma
-
B. Wiestler, D. Capper, M. Sill, D.T. Jones, V. Hovestadt, D. Sturm, C. Koelsche, A. Bertoni, L. Schweizer, A. Korshunov, E.K. Weiss, M.G. Schliesser, A. Radbruch, C. Herold-Mende, P. Roth, A. Unterberg, C. Hartmann, T. Pietsch, G. Reifenberger, P. Lichter, B. Radlwimmer, M. Platten, S.M. Pfister, A. von Deimling, M. Weller, and W. Wick Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma Acta Neuropathol 128 2014 561 571
-
(2014)
Acta Neuropathol
, vol.128
, pp. 561-571
-
-
Wiestler, B.1
Capper, D.2
Sill, M.3
Jones, D.T.4
Hovestadt, V.5
Sturm, D.6
Koelsche, C.7
Bertoni, A.8
Schweizer, L.9
Korshunov, A.10
Weiss, E.K.11
Schliesser, M.G.12
Radbruch, A.13
Herold-Mende, C.14
Roth, P.15
Unterberg, A.16
Hartmann, C.17
Pietsch, T.18
Reifenberger, G.19
Lichter, P.20
Radlwimmer, B.21
Platten, M.22
Pfister, S.M.23
Von Deimling, A.24
Weller, M.25
Wick, W.26
more..
-
15
-
-
84932649039
-
Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors
-
J.E. Eckel-Passow, D.H. Lachance, A.M. Molinaro, K.M. Walsh, P.A. Decker, H. Sicotte, and et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors N Engl J Med 372 2015 2499 2508
-
(2015)
N Engl J Med
, vol.372
, pp. 2499-2508
-
-
Eckel-Passow, J.E.1
Lachance, D.H.2
Molinaro, A.M.3
Walsh, K.M.4
Decker, P.A.5
Sicotte, H.6
-
16
-
-
84862173149
-
SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips
-
J. Maksimovic, L. Gordon, and A. Oshlack SWAN: subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips Genome Biol 13 2012 R44
-
(2012)
Genome Biol
, vol.13
, pp. R44
-
-
Maksimovic, J.1
Gordon, L.2
Oshlack, A.3
-
17
-
-
84876538609
-
Low-level processing of Illumina Infinium DNA Methylation BeadArrays
-
T.J. Triche Jr., D.J. Weisenberger, D. Van Den Berg, P.W. Laird, and K.D. Siegmund Low-level processing of Illumina Infinium DNA Methylation BeadArrays Nucleic Acids Res 41 2013 e90
-
(2013)
Nucleic Acids Res
, vol.41
, pp. e90
-
-
Triche, T.J.1
Weisenberger, D.J.2
Van Den Berg, D.3
Laird, P.W.4
Siegmund, K.D.5
-
18
-
-
84893325381
-
ChAMP: 450k Chip Analysis Methylation Pipeline
-
T.J. Morris, L.M. Butcher, A. Feber, A.E. Teschendorff, A.R. Chakravarthy, T.K. Wojdacz, and S. Beck ChAMP: 450k Chip Analysis Methylation Pipeline Bioinformatics 30 2014 428 430
-
(2014)
Bioinformatics
, vol.30
, pp. 428-430
-
-
Morris, T.J.1
Butcher, L.M.2
Feber, A.3
Teschendorff, A.E.4
Chakravarthy, A.R.5
Wojdacz, T.K.6
Beck, S.7
-
19
-
-
84904817499
-
Using high-density DNA methylation arrays to profile copy number alterations
-
A. Feber, P. Guilhamon, M. Lechner, T. Fenton, G.A. Wilson, C. Thirlwell, T.J. Morris, A.M. Flanagan, A.E. Teschendorff, J.D. Kelly, and S. Beck Using high-density DNA methylation arrays to profile copy number alterations Genome Biol 15 2014 R30
-
(2014)
Genome Biol
, vol.15
, pp. R30
-
-
Feber, A.1
Guilhamon, P.2
Lechner, M.3
Fenton, T.4
Wilson, G.A.5
Thirlwell, C.6
Morris, T.J.7
Flanagan, A.M.8
Teschendorff, A.E.9
Kelly, J.D.10
Beck, S.11
-
20
-
-
84924286644
-
Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma
-
S. Kurscheid, P. Bady, D. Sciuscio, I. Samarzija, T. Shay, I. Vassallo, W.V. Criekinge, R.T. Daniel, M.J. van den Bent, C. Marosi, M. Weller, W.P. Mason, E. Domany, R. Stupp, M. Delorenzi, and M.E. Hegi Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma Genome Biol 16 2015 16
-
(2015)
Genome Biol
, vol.16
, pp. 16
-
-
Kurscheid, S.1
Bady, P.2
Sciuscio, D.3
Samarzija, I.4
Shay, T.5
Vassallo, I.6
Criekinge, W.V.7
Daniel, R.T.8
Van Den Bent, M.J.9
Marosi, C.10
Weller, M.11
Mason, W.P.12
Domany, E.13
Stupp, R.14
Delorenzi, M.15
Hegi, M.E.16
-
21
-
-
46449115281
-
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
-
A. Murat, E. Migliavacca, T. Gorlia, W.L. Lambiv, T. Shay, M.F. Hamou, N. de Tribolet, L. Regli, W. Wick, M.C. Kouwenhoven, J.A. Hainfellner, F.L. Heppner, P.Y. Dietrich, Y. Zimmer, J.G. Cairncross, R.C. Janzer, E. Domany, M. Delorenzi, R. Stupp, and M.E. Hegi Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma J Clin Oncol 26 2008 3015 3024
-
(2008)
J Clin Oncol
, vol.26
, pp. 3015-3024
-
-
Murat, A.1
Migliavacca, E.2
Gorlia, T.3
Lambiv, W.L.4
Shay, T.5
Hamou, M.F.6
De Tribolet, N.7
Regli, L.8
Wick, W.9
Kouwenhoven, M.C.10
Hainfellner, J.A.11
Heppner, F.L.12
Dietrich, P.Y.13
Zimmer, Y.14
Cairncross, J.G.15
Janzer, R.C.16
Domany, E.17
Delorenzi, M.18
Stupp, R.19
Hegi, M.E.20
more..
-
22
-
-
77952108366
-
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma
-
H. Noushmehr, D.J. Weisenberger, K. Diefes, H.S. Phillips, K. Pujara, B.P. Berman, F. Pan, C.E. Pelloski, E.P. Sulman, K.P. Bhat, R.G. Verhaak, K.A. Hoadley, D.N. Hayes, C.M. Perou, H.K. Schmidt, L. Ding, R.K. Wilson, D. Van Den Berg, H. Shen, H. Bengtsson, P. Neuvial, L.M. Cope, J. Buckley, J.G. Herman, S.B. Baylin, P.W. Laird, K. Aldape Cancer Genome Atlas Research Network Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma Cancer Cell 17 2010 510 522
-
(2010)
Cancer Cell
, vol.17
, pp. 510-522
-
-
Noushmehr, H.1
Weisenberger, D.J.2
Diefes, K.3
Phillips, H.S.4
Pujara, K.5
Berman, B.P.6
Pan, F.7
Pelloski, C.E.8
Sulman, E.P.9
Bhat, K.P.10
Verhaak, R.G.11
Hoadley, K.A.12
Hayes, D.N.13
Perou, C.M.14
Schmidt, H.K.15
Ding, L.16
Wilson, R.K.17
Van Den Berg, D.18
Shen, H.19
Bengtsson, H.20
Neuvial, P.21
Cope, L.M.22
Buckley, J.23
Herman, J.G.24
Baylin, S.B.25
Laird, P.W.26
Aldape, K.27
more..
-
23
-
-
54549108740
-
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
-
Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 2008 1061 1068
-
(2008)
Nature
, vol.455
, pp. 1061-1068
-
-
-
24
-
-
84932628860
-
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas
-
Cancer Genome Atlas Research Network D.J. Brat, R.G. Verhaak, K.D. Aldape, W.K. Yung, S.R. Salama, L.A. Cooper, and et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas N Engl J Med 372 2015 2481 2498
-
(2015)
N Engl J Med
, vol.372
, pp. 2481-2498
-
-
Brat, D.J.1
Verhaak, R.G.2
Aldape, K.D.3
Yung, W.K.4
Salama, S.R.5
Cooper, L.A.6
-
25
-
-
78649475003
-
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis
-
P. Du, X. Zhang, C.C. Huang, N. Jafari, W.A. Kibbe, L. Hou, and S.M. Lin Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis BMC Bioinformatics 11 2010 587
-
(2010)
BMC Bioinformatics
, vol.11
, pp. 587
-
-
Du, P.1
Zhang, X.2
Huang, C.C.3
Jafari, N.4
Kibbe, W.A.5
Hou, L.6
Lin, S.M.7
-
27
-
-
54949156063
-
Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios
-
J. Staaf, J. Vallon-Christersson, D. Lindgren, G. Juliusson, R. Rosenquist, M. Hoglund, A. Borg, and M. Ringner Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios BMC Bioinformatics 9 2008 409
-
(2008)
BMC Bioinformatics
, vol.9
, pp. 409
-
-
Staaf, J.1
Vallon-Christersson, J.2
Lindgren, D.3
Juliusson, G.4
Rosenquist, R.5
Hoglund, M.6
Borg, A.7
Ringner, M.8
-
28
-
-
65449165989
-
Smoothing waves in array CGH tumor profiles
-
M.A. van de Wiel, R. Brosens, P.H. Eilers, C. Kumps, G.A. Meijer, B. Menten, E. Sistermans, F. Speleman, M.E. Timmerman, and B. Ylstra Smoothing waves in array CGH tumor profiles Bioinformatics 25 2009 1099 1104
-
(2009)
Bioinformatics
, vol.25
, pp. 1099-1104
-
-
Van De Wiel, M.A.1
Brosens, R.2
Eilers, P.H.3
Kumps, C.4
Meijer, G.A.5
Menten, B.6
Sistermans, E.7
Speleman, F.8
Timmerman, M.E.9
Ylstra, B.10
-
29
-
-
34248523183
-
CGHcall: Calling aberrations for array CGH tumor profiles
-
M.A. van de Wiel, K.I. Kim, S.J. Vosse, W.N. van Wieringen, S.M. Wilting, and B. Ylstra CGHcall: calling aberrations for array CGH tumor profiles Bioinformatics 23 2007 892 894
-
(2007)
Bioinformatics
, vol.23
, pp. 892-894
-
-
Van De Wiel, M.A.1
Kim, K.I.2
Vosse, S.J.3
Van Wieringen, W.N.4
Wilting, S.M.5
Ylstra, B.6
-
30
-
-
3543105225
-
Circular binary segmentation for the analysis of array-based DNA copy number data
-
A.B. Olshen, E.S. Venkatraman, R. Lucito, and M. Wigler Circular binary segmentation for the analysis of array-based DNA copy number data Biostatistics 5 2004 557 572
-
(2004)
Biostatistics
, vol.5
, pp. 557-572
-
-
Olshen, A.B.1
Venkatraman, E.S.2
Lucito, R.3
Wigler, M.4
-
31
-
-
0001876747
-
Algorithm AS159. An efficient method of generating r x c tables with given row and column totals
-
W.M. Patefield Algorithm AS159. An efficient method of generating r x c tables with given row and column totals Appl Stat 30 1981 91 97
-
(1981)
Appl Stat
, vol.30
, pp. 91-97
-
-
Patefield, W.M.1
-
33
-
-
77949568386
-
An exact permutation method for testing any effect in balanced and unbalanced fixed effect ANOVA
-
S. Kherad-Pajouh, and O. Renaud An exact permutation method for testing any effect in balanced and unbalanced fixed effect ANOVA Comput Stat Data Anal 54 2010 1881 1893
-
(2010)
Comput Stat Data Anal
, vol.54
, pp. 1881-1893
-
-
Kherad-Pajouh, S.1
Renaud, O.2
-
34
-
-
0032874498
-
Interpreting validity indexes for diagnostic tests: An illustration using the Berg balance test
-
D.L. Riddle, and P.W. Stratford Interpreting validity indexes for diagnostic tests: an illustration using the Berg balance test Phys Ther 79 1999 939 948
-
(1999)
Phys Ther
, vol.79
, pp. 939-948
-
-
Riddle, D.L.1
Stratford, P.W.2
-
35
-
-
59849104111
-
Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis
-
J.D. Lewis, S. Chuai, L. Nessel, G.R. Lichtenstein, F.N. Aberra, and J.H. Ellenberg Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis Inflamm Bowel Dis 14 2008 1660 1666
-
(2008)
Inflamm Bowel Dis
, vol.14
, pp. 1660-1666
-
-
Lewis, J.D.1
Chuai, S.2
Nessel, L.3
Lichtenstein, G.R.4
Aberra, F.N.5
Ellenberg, J.H.6
-
37
-
-
16244366026
-
Index for rating diagnostic tests
-
W.J. Youden Index for rating diagnostic tests Cancer 3 1950 32 35
-
(1950)
Cancer
, vol.3
, pp. 32-35
-
-
Youden, W.J.1
-
38
-
-
0016729922
-
The accuracy of diver sound localization by pointing
-
S.H. Feinstein The accuracy of diver sound localization by pointing Undersea Biomed Res 2 1975 173 184
-
(1975)
Undersea Biomed Res
, vol.2
, pp. 173-184
-
-
Feinstein, S.H.1
-
39
-
-
84973587732
-
A Coefficient of agreement for nominal scales
-
J. Cohen A Coefficient of agreement for nominal scales Educ Psychol Meas 20 1960 37 46
-
(1960)
Educ Psychol Meas
, vol.20
, pp. 37-46
-
-
Cohen, J.1
-
41
-
-
0942279488
-
Generating mutations but providing chemosensitivity: The role of O6-methylguanine DNA methyltransferase in human cancer
-
M. Esteller, and J.G. Herman Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer Oncogene 23 2004 1 8
-
(2004)
Oncogene
, vol.23
, pp. 1-8
-
-
Esteller, M.1
Herman, J.G.2
-
42
-
-
84923311865
-
Methylation of MGMT and ADAMTS14 in normal colon mucosa: Biomarkers of a field defect for cancerization preferentially targeting elder African-Americans
-
S. Alonso, Y. Dai, K. Yamashita, S. Horiuchi, T. Dai, A. Matsunaga, R. Sánchez-Muñoz, C. Bilbao-Sieyro, J.C. Díaz-Chico, A.V. Chernov, A.Y. Strongin, and M. Perucho Methylation of MGMT and ADAMTS14 in normal colon mucosa: biomarkers of a field defect for cancerization preferentially targeting elder African-Americans Oncotarget 6 2015 3420 3431
-
(2015)
Oncotarget
, vol.6
, pp. 3420-3431
-
-
Alonso, S.1
Dai, Y.2
Yamashita, K.3
Horiuchi, S.4
Dai, T.5
Matsunaga, A.6
Sánchez-Muñoz, R.7
Bilbao-Sieyro, C.8
Díaz-Chico, J.C.9
Chernov, A.V.10
Strongin, A.Y.11
Perucho, M.12
-
43
-
-
77954940774
-
Novel methylation panel for the early detection of colorectal tumors in stool DNA
-
D. Azuara, F. Rodriguez-Moranta, J. de Oca, A. Soriano-Izquierdo, J. Mora, J. Guardiola, S. Biondo, I. Blanco, M.A. Peinado, V. Moreno, M. Esteller, and G. Capellá Novel methylation panel for the early detection of colorectal tumors in stool DNA Clin Colorectal Cancer 9 2010 168 176
-
(2010)
Clin Colorectal Cancer
, vol.9
, pp. 168-176
-
-
Azuara, D.1
Rodriguez-Moranta, F.2
De Oca, J.3
Soriano-Izquierdo, A.4
Mora, J.5
Guardiola, J.6
Biondo, S.7
Blanco, I.8
Peinado, M.A.9
Moreno, V.10
Esteller, M.11
Capellá, G.12
-
44
-
-
84879903793
-
Evaluation of methylation of MGMT (O(6)-methylguanine-DNA methyltransferase) gene promoter in sporadic colorectal cancer
-
M. Farzanehfar, H. Vossoughinia, R. Jabini, A. Tavassoli, H. Saadatnia, A.K. Khorashad, M. Ahadi, M. Afzalaghaee, E. Ghayoor Karimiani, F. Mirzaei, and H. Ayatollahi Evaluation of methylation of MGMT (O(6)-methylguanine-DNA methyltransferase) gene promoter in sporadic colorectal cancer DNA Cell Biol 32 2013 371 377
-
(2013)
DNA Cell Biol
, vol.32
, pp. 371-377
-
-
Farzanehfar, M.1
Vossoughinia, H.2
Jabini, R.3
Tavassoli, A.4
Saadatnia, H.5
Khorashad, A.K.6
Ahadi, M.7
Afzalaghaee, M.8
Ghayoor Karimiani, E.9
Mirzaei, F.10
Ayatollahi, H.11
-
45
-
-
79951726143
-
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers
-
K. Shima, T. Morikawa, Y. Baba, K. Nosho, M. Suzuki, M. Yamauchi, M. Hayashi, E. Giovannucci, C.S. Fuchs, and S. Ogino MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers Cancer Causes Control 22 2011 301 309
-
(2011)
Cancer Causes Control
, vol.22
, pp. 301-309
-
-
Shima, K.1
Morikawa, T.2
Baba, Y.3
Nosho, K.4
Suzuki, M.5
Yamauchi, M.6
Hayashi, M.7
Giovannucci, E.8
Fuchs, C.S.9
Ogino, S.10
-
46
-
-
19244370208
-
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis
-
M. Esteller, M. Toyota, M. Sanchez-Cespedes, G. Capella, M.A. Peinado, D.N. Watkins, J.P. Issa, D. Sidransky, S.B. Baylin, and J.G. Herman Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis Cancer Res 60 2000 2368 2371
-
(2000)
Cancer Res
, vol.60
, pp. 2368-2371
-
-
Esteller, M.1
Toyota, M.2
Sanchez-Cespedes, M.3
Capella, G.4
Peinado, M.A.5
Watkins, D.N.6
Issa, J.P.7
Sidransky, D.8
Baylin, S.B.9
Herman, J.G.10
-
47
-
-
80052829123
-
Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence
-
K.H. Lee, J.S. Lee, J.H. Nam, C. Choi, M.C. Lee, C.S. Park, S.W. Juhng, and J.H. Lee Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence Langenbecks Arch Surg 396 2011 1017 1026
-
(2011)
Langenbecks Arch Surg
, vol.396
, pp. 1017-1026
-
-
Lee, K.H.1
Lee, J.S.2
Nam, J.H.3
Choi, C.4
Lee, M.C.5
Park, C.S.6
Juhng, S.W.7
Lee, J.H.8
-
48
-
-
84899066134
-
Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: Correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism
-
F. Coppedè, F. Migheli, A. Lopomo, A. Failli, A. Legitimo, R. Consolini, G. Fontanini, E. Sensi, A. Servadio, M. Seccia, G. Zocco, M. Chiarugi, R. Spisni, and L. Migliore Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism Epigenetics 9 2014 621 633
-
(2014)
Epigenetics
, vol.9
, pp. 621-633
-
-
Coppedè, F.1
Migheli, F.2
Lopomo, A.3
Failli, A.4
Legitimo, A.5
Consolini, R.6
Fontanini, G.7
Sensi, E.8
Servadio, A.9
Seccia, M.10
Zocco, G.11
Chiarugi, M.12
Spisni, R.13
Migliore, L.14
-
49
-
-
77954954112
-
Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas
-
J. Kim, J. Choi, S. Roh, D. Cho, T. Kim, and Y. Kim Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas Ann Surg Oncol 17 2010 1767 1776
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 1767-1776
-
-
Kim, J.1
Choi, J.2
Roh, S.3
Cho, D.4
Kim, T.5
Kim, Y.6
-
50
-
-
67049096814
-
The association of methylation in the promoter of APC and MGMT and the prognosis of Taiwanese CRC patients
-
S.P. Chen, S.C. Chiu, C.C. Wu, S.Z. Lin, J.C. Kang, Y.L. Chen, P.C. Lin, C.Y. Pang, and H.J. Harn The association of methylation in the promoter of APC and MGMT and the prognosis of Taiwanese CRC patients Genet Test Mol Biomarkers 13 2009 67 71
-
(2009)
Genet Test Mol Biomarkers
, vol.13
, pp. 67-71
-
-
Chen, S.P.1
Chiu, S.C.2
Wu, C.C.3
Lin, S.Z.4
Kang, J.C.5
Chen, Y.L.6
Lin, P.C.7
Pang, C.Y.8
Harn, H.J.9
-
51
-
-
34247129670
-
Comethylation of p16 and MGMT genes in colorectal carcinoma: Correlation with clinicopathological features and prognostic value
-
K. Krtolica, M. Krajnovic, S. Usaj-Knezevic, D. Babic, D. Jovanovic, and B. Dimitrijevic Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value World J Gastroenterol 13 2007 1187 1194
-
(2007)
World J Gastroenterol
, vol.13
, pp. 1187-1194
-
-
Krtolica, K.1
Krajnovic, M.2
Usaj-Knezevic, S.3
Babic, D.4
Jovanovic, D.5
Dimitrijevic, B.6
-
52
-
-
42549125175
-
Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis
-
T. Nagasaka, A. Goel, K. Notohara, T. Takahata, H. Sasamoto, T. Uchida, N. Nishida, N. Tanaka, C.R. Boland, and N. Matsubara Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis Int J Cancer 122 2008 2429 2436
-
(2008)
Int J Cancer
, vol.122
, pp. 2429-2436
-
-
Nagasaka, T.1
Goel, A.2
Notohara, K.3
Takahata, T.4
Sasamoto, H.5
Uchida, T.6
Nishida, N.7
Tanaka, N.8
Boland, C.R.9
Matsubara, N.10
-
53
-
-
0242610375
-
Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases
-
T. Nagasaka, G.B. Sharp, K. Notohara, T. Kambara, H. Sasamoto, H. Isozaki, D.G. MacPhee, J.R. Jass, N. Tanaka, and N. Matsubara Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases Clin Cancer Res 9 2003 5306 5312
-
(2003)
Clin Cancer Res
, vol.9
, pp. 5306-5312
-
-
Nagasaka, T.1
Sharp, G.B.2
Notohara, K.3
Kambara, T.4
Sasamoto, H.5
Isozaki, H.6
MacPhee, D.G.7
Jass, J.R.8
Tanaka, N.9
Matsubara, N.10
-
54
-
-
84904064217
-
Radiation therapy and concurrent plus adjuvant temsirolimus (CCI-779) versus chemoirradiation with temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter
-
abstract # 2003
-
W. Wick, T. Gorlia, M.J. van den Bent, C.J. Vecht, J. Steuve, A.A. Brandes, M. Platten, M.A. Kosch, M.E. Hegi, B. Lhermitte, V. Golfinopoulos, M. Campone, J.S. Frenel, M.J. Taphoorn, G.A. Pesce, and P. Roth Radiation therapy and concurrent plus adjuvant temsirolimus (CCI-779) versus chemoirradiation with temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter J Clin Oncol 32 2014 5s abstract # 2003
-
(2014)
J Clin Oncol
, vol.32
, pp. 5s
-
-
Wick, W.1
Gorlia, T.2
Van Den Bent, M.J.3
Vecht, C.J.4
Steuve, J.5
Brandes, A.A.6
Platten, M.7
Kosch, M.A.8
Hegi, M.E.9
Lhermitte, B.10
Golfinopoulos, V.11
Campone, M.12
Frenel, J.S.13
Taphoorn, M.J.14
Pesce, G.A.15
Roth, P.16
-
55
-
-
84880791777
-
Molecular neuro-oncology in clinical practice: A new horizon
-
M. Weller, S.M. Pfister, W. Wick, M.E. Hegi, G. Reifenberger, and R. Stupp Molecular neuro-oncology in clinical practice: a new horizon Lancet Oncol 14 2013 e370 e379
-
(2013)
Lancet Oncol
, vol.14
, pp. e370-e379
-
-
Weller, M.1
Pfister, S.M.2
Wick, W.3
Hegi, M.E.4
Reifenberger, G.5
Stupp, R.6
-
56
-
-
84877095945
-
Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer
-
A. Amatu, A. Sartore-Bianchi, C. Moutinho, A. Belotti, K. Bencardino, G. Chirico, A. Cassingena, F. Rusconi, A. Esposito, M. Nichelatti, M. Esteller, and S. Siena Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer Clin Cancer Res 19 2013 2265 2272
-
(2013)
Clin Cancer Res
, vol.19
, pp. 2265-2272
-
-
Amatu, A.1
Sartore-Bianchi, A.2
Moutinho, C.3
Belotti, A.4
Bencardino, K.5
Chirico, G.6
Cassingena, A.7
Rusconi, F.8
Esposito, A.9
Nichelatti, M.10
Esteller, M.11
Siena, S.12
-
57
-
-
67649197934
-
Ratio adjustment and calibration scheme for gene-wise normalization to enhance microarray inter-study prediction
-
C. Cheng, K. Shen, C. Song, J. Luo, and G.C. Tseng Ratio adjustment and calibration scheme for gene-wise normalization to enhance microarray inter-study prediction Bioinformatics 25 2009 1655 1661
-
(2009)
Bioinformatics
, vol.25
, pp. 1655-1661
-
-
Cheng, C.1
Shen, K.2
Song, C.3
Luo, J.4
Tseng, G.C.5
-
58
-
-
84897548625
-
Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
-
M.J. Aryee, A.E. Jaffe, H. Corrada-Bravo, C. Ladd-Acosta, A.P. Feinberg, K.D. Hansen, and R.A. Irizarry Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays Bioinformatics 30 2014 1363 1369
-
(2014)
Bioinformatics
, vol.30
, pp. 1363-1369
-
-
Aryee, M.J.1
Jaffe, A.E.2
Corrada-Bravo, H.3
Ladd-Acosta, C.4
Feinberg, A.P.5
Hansen, K.D.6
Irizarry, R.A.7
|